On Behalf of Williams DeClark Tuschman Co. L.P.A. | May 11, 2015 | Personal Injury
We are happy to have William DeClak Tuschman’s own, Chad Tuschman, become a member of the BlueBook Society. The BlueBook Society is a trusted and credible source to find the best attorneys throughout the U.S. and we are glad to have personanl injury specialist, Chad...
| May 4, 2015 | Firm News
A review by the U.S. Food and Drug Administration (FDA) has found that the AstraZeneca Plc’s diabetes drug, Onglyza, may be associated with an increased rate of death. A trial was underway of more than 16,000 patients taking Onglyza. It has been reported that these...